From killer to saver, that is a fascinating journey for tobacco, indeed.
Yes, US scientists are using a modified tobacco virus to deliver delicate gene therapies. Could become useful in treatment of cancer and genetic disorders.
The tobacco mosaic virus, which plagues the plant but is harmless to humans, is hollowed out and filled with "small interfering RNA" molecules, or siRNA, which some scientists consider to be the most significant development in medicine since the discovery of vaccines.
The virus' tubular shell provides a safe way to slip the delicate siRNA drugs into cells, serving as both a protective coating and a Trojan horse.
"This tobacco mosaic virus is literally a nano-sized syringe," says William Bentley, a professor of bioengineering at the University of Maryland, who is leading the study of the virus.
Bentley's team has successfully hollowed out the virus and filled it with siRNA, and then used it to slip the frail substance into all sorts of cells, from kidney tissue to cancer. The researchers have proven that the tiny capsules provide adequate protection, and that they release their payloads once inside -- hitting their target genes right on the mark.
The short, double-stranded RNA molecules known as siRNA can program cells to destroy disease-causing proteins. Their molecules turn on a cell's own built-in disease-fighting mechanisms. They can be programmed for a wide range of ailments -- from cancers to viruses -- and because they use the cell's own defense mechanisms, they produce minimal side effects.